PRESS RELEASE
Leslie Titus Bryant
March  19, 2024

SALT LAKE CITY—March 19, 2024—Spectrum Solutions® today announced the official release of a new saliva diagnostic testing innovation, SimplyPERIO™. As advances in science and whole health understanding continue to focus in on the mouth-body connection and its direct link to systemic disease, SimplyPERIO™ fills a testing void by delivering more intelligent health measures with real clinical relevance using 16 oral targets from a single patient sample.

Gum disease, also called periodontal disease, is the most undiagnosed and untreated disease with the highest impact to so many bodily systems and functions. In addition, gum disease decreases a person’s ability to fight infection and inflammation.

In the U.S., numbers illustrate that 80% of individuals over 35 have a form of gum disease. Gingivitis, periodontitis, and periimplantitis are all forms of gum disease. These numbers demonstrate that for the vast majority, there may be dangerous and damaging periodontal disease pathogens hiding that can’t be identified with a perio-probe or visual exam during regular semi-annual cleanings. Gone unchecked, these harmful oral bacteria and toxins are allowed to sit and accumulate inside the mouth. From inside the mouth, these microorganisms move freely to and through the bloodstream with far-reaching and catastrophic effects on the heart, arteries, central nervous system, and more.

SimplyPERIO™ uses a proprietary molecular technology to test for and measure periodontal bacteria, caries, fungal, and viral targets all for one affordable cost. Understanding treatment success is often influenced by host immunity and host response, this unique, highly sensitive and highly specific saliva test offers Providers the real opportunity to elevate patient care with the most complete oral health picture.

“We are using science to make saliva diagnostics simple for both Patients and Providers. SimplyPERIO™ testing is not only pain-free, it takes less than 30 seconds for a patient to collect their own sample,” said Dr. David Vigerust, PhD, Chief Science Officer at Spectrum Solutions. “In addition, our CAP-accredited laboratory delivers Providers the independent, 3rd party results necessary for intelligent, data-supported patient conversations about stopping and even reversing their disease and systemic risks.”
The SimplyPERIO™ patented blue buffer solution located inside the collection device’s cap stabilizes saliva samples at room temperature, eliminating any special post-collection storage or shipping requirements. Easily deposit one at a time, supporting at-home patient testing for follow-up and treatment monitoring, or gather an entire day’s worth of in-office collections into the USPS postage-paid return box for mailing samples back to the lab for processing.

__________

Click here to view this press release on the Business Wire.